RE:Congratulations Thank you.... and I'm serious. Looking at revenue over the last 8 quarters we can see that the low point was in Q3 '23. That coincided with the stock-outs and supply chain issues.
Q4 '23 brings us back to where we were in Q1 '23. With the increase in number of retailers carrying not only the powdered baby/toddler formula but also the kids RTD as well as the removal of the manufacturing bottlenecks, at a much lower cost, Q1 '24 will see both top and bottom line improvements even without a Danone deal. I anticipate Q1 sales of >3M and FY '24 north of 20M.
A 3x forward revenue multiple puts us at roughly 0.40/share so yes, I am comfortable holding.